|
1）Kouskoff V, Korganow AS, Duchatelle V, et al. Organ-specific disease provoked by systemic autoimmunity. Cell. 1996; 87: 811-22
|
|
|
|
2）Matsumoto I, Staub A, Benoist C, et al. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science. 1999; 286: 1732-5
|
|
|
|
|
|
3）Maccioni M, Zeder-lutz G, Huang H, et al. Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med. 2002; 195: 1071-7
|
|
|
|
|
|
4）Matsumoto I, Maccioni M, Lee DM, et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint specific autoimmune disease. Nat Immunol. 2002; 3: 360-5
|
|
|
|
|
|
5）Ji H, Ohmura K, Mahmood U, et al. Arthritis critically dependent on innate immune system players. Immunity. 2002; 16: 157-68
|
|
|
|
|
|
6）Ji H, Pettit A, Ohmura K, et al. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med. 2002; 196: 77-85
|
|
|
|
|
|
7）Choe JY, Crain B, Wu SR, et al. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med. 2003; 197: 537-42
|
|
|
|
|
|
8）Wipke BT, Allen PM. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol. 2001; 167: 1601-8
|
|
|
|
|
|
9）Lee DM, Friend DS, Gurish MF, et al. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science. 2002; 297: 1689-92
|
|
|
|
|
|
10）Solomon S, Rajasekaran N, Jeisy-Walder E, et al. A crucial role for macrophages in the pathology of K/BxN serum-induced arthritis. Eur J Immunol. 2005; 35: 3064-73
|
|
|
|
|
|
11）Kim ND, Chou RC, Seung E, et al. A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis. J Exp Med. 2006; 203: 829-35
|
|
|
|
|
|
12）Chen M, Lam BK, Kanaoka Y, et al. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med. 2006; 203: 837-42
|
|
|
|
|
|
13）Nigrovic PA, Binstadt BA, Monach PA, et al. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci USA. 2007; 104: 2325-30
|
|
|
|
|
|
14）Kneilling M, Hultner L, Pichler BJ, et al. Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum. 2007; 56: 1806-16
|
|
|
|
|
|
15）Wipke BT, Wang Z, Nagengast W, et al. Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J Immunol. 2004; 172: 7694-702
|
|
|
|
|
|
16）Binstadt BA, Patel PR, Alencar H, et al. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol. 2006; 7: 284-92
|
|
|
|
|
|
17）Schubert D, Maier B, Morawietz L, et al. Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J Immunol. 2004; 172: 4503-9
|
|
|
|
|
|
18）Iwanami K, Matsumoto I, Tanaka-Watanabe Y, et al. Crucial role of IL-6/IL-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase. Arthritis Rheum. In press
|
|
|
|
|
|
19）Bockermann R, Schubert D, Kamradt T, et al. Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase. Arthritis Res Ther. 2005; 7: 1316-24
|
|
|
|
|
|
20）Schaller M, Burton DR, Ditzel HJ. Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat Immunol. 2001; 2: 746-53
|
|
|
|
|
|
21）Matsumoto I, Lee DM, Mansky RG, et al. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and spectrum of other chronic autoimmune disorders. Arthritis Rheum. 2003; 48: 944-54
|
|
|
|
|
|
22）van Gaalen FA, Toes RE, Ditzel HJ, et al. Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis. Arthritis Rheum. 2004; 50: 395-9
|
|
|
|
|
|
23）Saulot V, Vittecoq O, Charlionet R, et al. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum. 2002; 46: 1196-201
|
|
|
|
|
|
24）Schaller M, Stohl W, Benoit V, et al. Patients with inflammatory arthritic diseases harbor elevated serum and synovial fluid levels of free and immune-complexed glucose-6-phosphate isomerase (G6PI). Biochem Biophys Res Commun. 2006; 349: 838-45
|
|
|
|
|
|
25）Naughton DP. Hypoxia-induced upregulation of the glycolytic enzyme glucose-6-phosphate isomerase perpetuates rheumatoid arthritis. Med Hypotheses. 2003; 60: 332-4
|
|
|
|
|
|
26）Petkova SB, Konstantinov KN, Sproule TJ, et al. Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor Fc gamma RIIB. J Exp Med. 2006; 203: 275-80
|
|
|
|
|
|
27）Suzuki T, Muraki Y, Yasukochi T, et al. Immunoglobulin G from anti-glucose-6-phosphate isomerase antibodies positive patient with rheumatoid arthritis induces synovitis in cynomolgus monkeys. Autoimmun Rev. 2005; 4: 475-8
|
|
|
|
|
|
28）Matsumoto I, Zhang H, Muraki Y, et al. A functional variant of Fcg receptor IIIA is associated with rheumatoid arthritis in anti-glucose-6-phosphate isomerase antibodies-positive individuals. Arthritis Res Ther. 2005; 7: 1183-8
|
|
|
|
|
|
29）Kori Y, Matsumoto I, Zhang H, et al. Characterization of Th1/Th2 type, glucose-6-phosphate isomerase reactive T cells in the generation of rheumatoid arthritis. Ann Rheum Dis. 2006; 65: 968-9
|
|
|
|
|